Qiagen receives EUA for portable SARS-CoV-2 antigen test

LabPulse.com staff writers
Aug 5, 2021
2020 04 16 18 56 8041 Virus Coronavirus Sars Co V 2 400

Qiagen announced it has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration for its QIAreach SARS-CoV-2 Antigen Test, a rapid portable test that the company said can analyze over 30 samples per hour for the SARS-CoV-2 antigen.

The company touted its test, developed in collaboration with Ellume, as providing digital results in two to 15 minutes. It also uses Qiagen's Underwriters Laboratories (UL)-certified eHub, a portable reader with backup battery power that can be operated remotely from the main power for up to eight hours.

Latest in Infectious
3d Closeup Coronavirus Social
Rapid nirmatrelvir treatment in study reduced long-COVID risk
March 23, 2023
Nurse Doctor Patient Black Woman Social
Quest Diagnostics offers suite of services for transplant patients and living donors
March 23, 2023
Candida Candidiasis Social
Contagious fungal infections increase dramatically
March 21, 2023
Fda Button Social
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
March 20, 2023
Related Stories
2022 07 15 19 23 6017 White House 400
510(k)
Ellume COVID-19 test available at no cost to the blind
2021 11 08 22 23 6155 Settlement 400
PCR
Qiagen and BD settle PCR patent lawsuit
2019 12 03 00 00 5470 Tuberculosis Lungs 400
Tuberculosis
Qiagen launches new tuberculosis test
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400
Influenza
PerkinElmer receives EUA for respiratory SARS-CoV-2 panel
More in Infectious
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Nirmatrelvir treatment soon after a positive SARS-CoV-2 test result may reduce the chances of developing long COVID in people with risk factors.
March 23, 2023
3d Closeup Coronavirus Social
Quest Diagnostics offers suite of services for transplant patients and living donors
The offerings of the Quest Advanced Specialized Transplant Services suite include access to Quest’s national network of service centers and mobile phlebotomists for both recipients and living donors in the 48 contiguous U.S. states.
March 23, 2023
Nurse Doctor Patient Black Woman Social
Contagious fungal infections increase dramatically
Candidiasis infections caused by Candida auris, a highly contagious fungus, rose dramatically between 2019 and 2021, reflecting increased transmission.
March 21, 2023
Candida Candidiasis Social
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
The test detects and differentiates influenza A, influenza B, and SARS-CoV-2 viruses to help ensure physicians can recommend the most appropriate treatment for each patient.
March 20, 2023
Fda Button Social
Cue Health receives FDA emergency use authorization for molecular mpox test
The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.
March 20, 2023
Monkeypox Virus Social
Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples
The research shows the potential of using dried blood spot samples for determining cure rates and differentiating between reinfection and relapse after antiviral treatment in people who inject drugs.
March 20, 2023
Hepatitis C Virus Social
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
More in Infectious
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
The BD vaginal panel running on the high-throughput BD Cor molecular diagnostic system tests for multiple common types of vaginitis using only a swab and one test.
March 16, 2023
Bd Vaginal Panel Cor System
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
Lung Tuberculosis Art Social
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Hepatitis C Virus Social
Calibre Scientific acquires AlphaScience to expand product portfolio, customer reach
AlphaScience will be integrated with Biozol Diagnostica, a subsidiary of Calibre Scientific, expanding its sales capabilities and product range for customers in the DACH region that comprises Germany, Austria, and Switzerland.
March 13, 2023
Hands Shaking Deal Social
Electronic health record interventions reduce unnecessary urine culture orders, study finds
According to the study, electronic health record interventions can significantly reduce unnecessary urine culture orders, resulting in cost savings and improved patient care.
March 2, 2023
Lab Urine Test Social
Laser light method identifies bacteria in fluids
An innovative way of shining a laser on a minute drop of blood, mucus, or wastewater enables the reflected light to identify the bacteria within.
March 3, 2023
Bacteria Blood Sepsis Social
Page 1 of 140
Next Page